1CM
ETNB

1492 Capital Management’s 89bio ETNB Stock Holding History

1492 Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-79,168
Closed -$922K – 98
2024
Q1 		$922K Sell
79,168
-50
-0.1% -$554 0.51% 61
2023
Q4 		$885K Buy
79,218
+814
+1% +$7.48K 0.5% 68
2023
Q3 		$1.21M Hold
78,404
– – 0.78% 46
2023
Q2 		$1.49M Sell
78,404
-36
-0% -$632 0.87% 42
2023
Q1 		$1.19M Sell
78,440
-25
-0% -$326 0.74% 53
2022
Q4 		$999K Buy
+78,465
New +$706K 0.64% 50

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

1492 Capital Management's ETNB Position: Q2 2024 in Review

1492 Capital Management sold out of 89bio (ETNB) in Q2 2024, closing a stake of 79,168 shares — an estimated $922K sold.

1492 Capital Management first reported a position in ETNB in Q4 2022 and held it in 6 quarters. The position peaked at $1.49M in Q2 2023. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

  • 1492 Capital Management reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
  • 1492 Capital Management sold 79,168 89bio shares in Q2 2024, an estimated $922K.
  • 1492 Capital Management first reported a position in 89bio in Q4 2022 and held it in 6 quarters.
  • 1492 Capital Management's 89bio position peaked at $1.49M in Q2 2023.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on 1492 Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.